Medical Consumables
Capital Equipment
Brands
ProFound AI™ by iCAD
EchoNous Logo

ProFound AI™ by iCAD

Next Generation AI for Breast Cancer Detection

Proudly distributed across Australia & New Zealand by Regional Health Care Group

ProFound AI™ by iCAD
iCAD Logo

ProFound AI™ by iCAD

Next Generation AI for Breast Cancer Detection

Proudly distributed across Australia & New Zealand by Regional Health Care Group

Smarter Breast Cancer Detection, Powered by AI

Key Features

  • TGA Approved & FDA Cleared AI solution.

  • Up to 2× better detection performance compared to other AI platforms.

  • Provides case-level and lesion-level risk scores, including breast density analysis.

  • Supports 2D mammography and 3D tomosynthesis (DBT).

  • Seamless PACS integration and optional cloud-based deployment.

Market Reach & Proven Performance

  • Global Impact: Available in 50+ countries worldwide.

  • Proven Case Volume: The ProFound suite has analysed 40 million+ mammograms in the past 5 years, with nearly 30% using 3D tomosynthesis.

  • Cloud-Enabled: Since the launch of ProFound Cloud in the U.S., nearly 100,000 cases have been processed, demonstrating rapid adoption and scalability.

Mammogram
Clinical Applications

ProFound AI is designed to enhance diagnostic confidence across multiple scenarios:

  • Breast cancer screening & diagnostics.
  • Interpretation of 2D & 3D mammography.
  • Risk stratification & triage for high-volume screening.
  • Workflow optimisation in double-reading environments.
Mammogram
Benefits to Healthcare Providers
  • Earlier & more accurate detection of breast cancer.
  • Fewer unnecessary callbacks, reducing patient anxiety.
  • Improved efficiency: up to 52% shorter reading times
  • Greater consistency and confidence across radiology teams.